Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;50(2):395-403.
doi: 10.1007/s00125-006-0531-x. Epub 2006 Dec 29.

Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity

Affiliations

Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity

J T Wong et al. Diabetologia. 2007 Feb.

Abstract

Aims/hypothesis: Insulin controls glucose metabolism via multiple signalling pathways, including the phosphatidylinositol 3-kinase (PI3K) pathway in muscle and adipose tissue. The protein/lipid phosphatase Pten (phosphatase and tensin homologue deleted on chromosome 10) attenuates PI3K signalling by dephosphorylating the phosphatidylinositol 3,4,5-trisphosphate generated by PI3K. The current study was aimed at investigating the effect of haploinsufficiency for Pten on insulin-stimulated glucose uptake.

Materials and methods: Insulin sensitivity in Pten heterozygous (Pten(+/-)) mice was investigated in i.p. insulin challenge and glucose tolerance tests. Glucose uptake was monitored in vitro in primary cultures of myocytes from Pten(+/-) mice, and in vivo by positron emission tomography. The phosphorylation status of protein kinase B (PKB/Akt), a downstream signalling protein in the PI3K pathway, and glycogen synthase kinase 3beta (GSK3beta), a substrate of PKB/Akt, was determined by western immunoblotting.

Results: Following i.p. insulin challenge, blood glucose levels in Pten(+/-) mice remained depressed for up to 120 min, whereas glucose levels in wild-type mice began to recover after approximately 30 min. After glucose challenge, blood glucose returned to normal about twice as rapidly in Pten(+/-) mice. Enhanced glucose uptake was observed both in Pten(+/-) myocytes and in skeletal muscle of Pten(+/-) mice by PET. PKB and GSK3beta phosphorylation was enhanced and prolonged in Pten(+/-) myocytes.

Conclusions/interpretation: Pten is a key negative regulator of insulin-stimulated glucose uptake in vitro and in vivo. The partial reduction of Pten due to Pten haploinsufficiency is enough to elicit enhanced insulin sensitivity and glucose tolerance in Pten(+/-) mice.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Insulin hypersensitivity in Pten+/−mice. a Insulin challenge test. Mice were fasted for 15 h prior to i.p. injection of insulin (0.6 mU/g body weight). Blood glucose levels were determined at the indicated times. Means±SEM for six wild-type mice (white circles) and six Pten+/− mice (black circles). b Glucose tolerance test. Mice were fasted for 15 h prior to i.p. injection of glucose at 2 mg/g body weight. Means±SEM for six wild-type mice (white circles) and seven Pten+/− mice (black circles)
Fig. 2
Fig. 2
Pancreatic islet morphology and immunohistochemistry for insulin (green) and glucagon (red) in wild-type (a) and Pten+/− (b) mice. Pancreatic sections were immunostained as described in Materials and methods and visualised by fluorescence microscopy. Original magnification ×40
Fig. 3
Fig. 3
Insulin-stimulated uptake of 18FDG in wild-type and Pten+/− mice. Mice were fasted for 15 h prior to i.p. injection of 0.6 mU insulin/g body weight. Twenty minutes after insulin injection, mice were injected with 18FDG via a tail vein, and whole-body distribution of 18FDG was monitored by microPET for 60 min. The experiment was repeated three times with similar results. Typical results are shown. a–f Imaging of 18FDG distribution in coronal section; wild-type mouse is on the left and Pten+/− mouse is on the right (a 5 min; b 15 min; c 25 min; d 35 min; e 45 min; f 55 min). Hindlimb muscles were highlighted as regions of interest, and 18FDG activity in each region of interest quantified across coronal planes at each time-point, as described in Materials and methods. g Graphical representation of relative 18FDG activity. Data are shown as proportion of 18FDG activity in hindlimbs relative to activity in whole body for wild-type mice (circles) and Pten+/− mice (triangles) (mean±SD; n = 3 per point)
Fig. 4
Fig. 4
a 2-Deoxy[3H]glucose uptake in wild-type and Pten+/− myocytes. Myocytes were serum-starved for 12 h prior to incubation with 10 μmol/l 2-deoxy[3H]glucose (0.037 MBq/μmol/l) for the indicated times with 0 or 1 μmol/l insulin. Following incubation cells were lysed and aliquots of lysates were taken for determination of radioactivity by scintillation counting. Means±SD for three separate determinations. White circles, wild-type cells 0 μmol/l insulin; black circles, wild-type cells 1 μmol/l insulin; white triangles, Pten+/− cells 0 μmol/l insulin; black triangles, Pten+/− cells 1 μmol/l insulin. b Cell-surface GLUT1 and GLUT4 levels. Levels of cell-surface GLUT1 and GLUT4 proteins in wild-type (WT) and Pten+/− cells were determined as described in Materials and methods
Fig. 5
Fig. 5
Phosphorylation of PKB and GSK3β. Myocytes were serum-starved for 12 h prior to incubation with 1 μmol/l insulin for the indicated times. Cell lysates were prepared, and proteins were separated by PAGE followed by western immunoblot analysis for vinculin, total PKB, phospho-PKB (p-PKB S473) and phospho-GSK3β (p-GSK3β) as indicated. This experiment was repeated three times with typical results shown. WT, wild-type

Comment in

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0960-9822(02)00777-7', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0960-9822(02)00777-7'}, {'type': 'PubMed', 'value': '11937037', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11937037/'}]}
    2. Lizcano JM, Alessi DR (2002) The insulin signalling pathway. Curr Biol 12:R236–R238 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1074/jbc.273.22.13375', 'is_inner': False, 'url': 'https://doi.org/10.1074/jbc.273.22.13375'}, {'type': 'PubMed', 'value': '9593664', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9593664/'}]}
    2. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1073/pnas.95.23.13513', 'is_inner': False, 'url': 'https://doi.org/10.1073/pnas.95.23.13513'}, {'type': 'PMC', 'value': 'PMC24850', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC24850/'}, {'type': 'PubMed', 'value': '9811831', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9811831/'}]}
    2. Myers MP, Pass I, Batty IH et al (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95:13513–13518 - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1126/science.275.5308.1943', 'is_inner': False, 'url': 'https://doi.org/10.1126/science.275.5308.1943'}, {'type': 'PubMed', 'value': '9072974', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9072974/'}]}
    2. Li J, Yen C, Liaw D et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/ng0497-356', 'is_inner': False, 'url': 'https://doi.org/10.1038/ng0497-356'}, {'type': 'PubMed', 'value': '9090379', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9090379/'}]}
    2. Steck PA, Pershouse MA, Jasser SA et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362 - PubMed

Publication types

MeSH terms